Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
530635
Reference Type
Journal Article
Title
Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia
Author(s)
van der Kooij, MA; Groenendaal, F; Kavelaars, A; Heijnen, CJ; van Bel, F
Year
2008
Is Peer Reviewed?
Yes
Journal
Brain Research Reviews
ISSN:
0165-0173
Volume
59
Issue
1
Page Numbers
22-33
Language
English
DOI
10.1016/j.brainresrev.2008.04.007
Abstract
Besides its established function in erythropoiesis, erythropoietin (EPO) is currently also appreciated for its neuroprotective effects. The detrimental sequelae of prolonged cerebral hypoxia and ischemia have been shown to attenuate by EPO treatment. After binding to the EPO receptor, EPO is capable of initiating a cascade of events which -via different pathways-may lead to neuroprotection. The circumstances that determine which specific signalling route(s) are activated by EPO are largely unknown. We aim to provide the reader with a timely overview on the use of EPO in models of stroke and hypoxia-ischemia and to discuss the molecular events that underlie its neuroprotection. (C) 2008 Elsevier B.V. All rights reserved.
Keywords
Erythropoietin; Hypoxia; Ischemia; Mechanism; Neuroprotection; Review; neonatal hypoxia-ischemia; focal cerebral-ischemia; blood-brain-barrier; dose recombinant erythropoietin; colony-stimulating factor; postnatal day-7 rats; common beta-subunit; nf-kappa-b; neuronal apoptosis; carbamylated erythropoietin
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity